ESIP calls for patient-centered data spaces 31-07-2020


Feedback to the Commission's roadmap on Common European Data Spaces

Following the publication of the roadmap on a new 'Legislative framework for the governance of common European data spaces', ESIP released today its feedback on the creation of a Single Market for data. Among the sectoral European data spaces envisaged is one on health. ESIP overall welcomes the Commission’s initiative to increase and improve the accessibility, usability and interoperability of data – both held by public sector bodies and consented data voluntarily provided by individuals and companies. The initiative also aims at reducing the costs of data transformation and transaction.

Health is wealth: for a strong EU health policy 24-07-2020


ESIP calls for a more ambitious EU4Health Programme

On 21 July, European leaders reached an agreement on the EU budget for the next seven years for a total amount of €1.074 billion. They also agreed on the temporary Next Generation EU instrument providing an additional €750 billion to support economic recovery which will be raised on the financial markets by the European Commission on behalf of the EU.

Building a balanced pharma strategy 07-07-2020


First insights into the Pharmaceutical Strategy Roadmap

As the European Commission launches the debate on the future Pharmaceutical Strategy for Europe, ESIP provided its first insights to the published roadmap. ESIP overall welcomes the Commission’s initiative and calls for a balanced approach taking into consideration both access to innovation that responds to unmet medical need and support to the financial sustainability of health systems.

Setting the path towards fair medicine prices 06-07-2020


Joint statement of EU public health stakeholders

Current pharmaceutical prices are set at levels that come at the expense of the access for patients and the sustainability of healthcare systems. As a result, a reflection on fair medicines has gained traction over the past years. A coalition of 12 European and international organisations, including ESIP, put forward recommendations for the EU to reach fairer drug pricing.